FindTrial
Sign In

Cervical cerclage as a prophylactic intervention in patients with cervical insufficiency: a multicenter cluster randomized controlled trial

Prophylactic intervention in patients with cervical insufficiency: a multicenter cluster randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029721
Enrollment
Unknown
Registered
2020-02-10
Start date
2020-02-07
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical insufficiency

Interventions

contrast group:vaginal progesterone
Intensive treatment group:cervical cerclage

Sponsors

West China second hospital, Sichuan university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with a previous late abortion and cervical length (CL) < 25mm measured by transvaginal ultrasound before 26 weeks of pregnancy; 2. Patients with Two or more second-trimester abortions or premature births.

Exclusion criteria

Exclusion criteria: 1. Serious medical and hematological diseases, thyroid dysfunction, pregnancy complicated with serious hypertension, diabetes, fetal chromosomal abnormalities or congenital developmental malformations, etc; 2. Genital tract infection.

Design outcomes

Primary

MeasureTime frame
<34 weeks delivery rate;—

Secondary

MeasureTime frame
<32 weeks delivery rate;<30 weeks delivery rate;<28 weeks delivery rate;<32 weeks live birth rate;<30 weeks live birth rate;<28 weeks live birth rate;Neonatal mortality;Adverse neonatal outcome;Incidence of postpartum hemorrhage;Incidence of maternal mortality;—

Countries

China

Contacts

Public ContactLiu Xinghui

West China second hospital of sichuan university

xinghuiliu@163.com+86 13881883798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026